David Nakasane
Head of Investor Relations
Replay available
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2025 Earnings Call
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bobby Azamian
Chief Executive Officer and Chairman
Aziz Madawala
Chief Commercial Officer
Jeff Farrell
Chief Financial Officer and Chief Strategy Officer
Eddie Hickman
Analyst, Guggenheim Securities
Andrea Newkirk
Analyst, Goldman Sachs
Jason Gerberry
Analyst, Bank of America
Corey Jubinville
Analyst, LifeSci Capital
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tarsus Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.116 Good afternoon, ladies and gentlemen, and thank you for standing by. 00:00:03.116 -- 00:00:08.384 Welcome to TARSA's second quarter 2025 earnings conference call. 00:00:08.384 -- 00:00:10.568 As a reminder, this call is being recorded. 00:00:10.568 -- 00:00:15.596 At this time, I would like to turn the call over to David Nakasane, head of investor 00:00:15.596 -- 00:00:20.260 relations, to lead off the call. David, you may begin. 00:00:21.513 -- 00:00:25.717 Thank you. Before we begin, I encourage everyone to visit the investor section of the 00:00:25.717 -- 00:00:29.920 TARCIS website to view the earnings release and related materials we will be discussing 00:00:29.920 -- 00:00:35.125 today. Joining me on the call this afternoon are Bobby Azamian, our Chief Executive 00:00:35.125 -- 00:00:39.548 Officer and Chairman, Aziz Madawala, our Chief Commercial Officer, and Jeff Farrell, 00:00:39.548 -- 00:00:43.312 our Chief Financial Officer and Chief Strategy Officer. 00:00:43.312 -- 00:00:47.976 I'd like to draw your attention to slide three, which contains our forward-looking statements. 00:00:47.976 -- 00:00:51.846 During this call, we will be making forward-looking statements that are based on our 00:00:51.846 -- 00:00:56.871 current expectations and beliefs. These statements are subject to certain risks and 00:00:56.871 -- 00:01:00.975 uncertainties, and our actual results may differ materially. 00:01:00.975 -- 00:01:05.360 I encourage you to consult the risk factors contained in our SEC filings for additional 00:01:05.360 -- 00:01:10.005 details. With that, I will turn the call over to Bobby. 00:01:10.005 -- 00:01:14.570 Thank you, Dave. Good afternoon, everyone, and thank you for joining us. 00:01:14.570 -- 00:01:18.061 We are ap...